SCHEMBL2465447

SCHEMBL2465447

Fc1ccc(OC(=S)Oc2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
RECQL P46063 1/20 0.42
ALOX15 P16050 1/20 0.42
NOX1 Q9Y5S8 1/20 0.41
PLA2G1B P04054 1/20 0.40
ATG4B Q9Y4P1 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
ATM Q13315 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
LTA4H P09960 2/20 0.38
EPHX2 P34913 1/20 0.38
FFAR1 O14842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470101 0.86 LTA4H (0.45) ALDH1A1RECQLALOX15ATMKDM4E
SCHEMBL22267283 0.80 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1RECQLPLA2G1B
SCHEMBL9051513 0.79 MAOA (0.42) ALDH1A1KMT2AMEN1RECQLNOX1
SCHEMBL23731325 0.79 ALOX15 (0.41) ALDH1A1KMT2AMEN1RECQLALOX15
SCHEMBL19943304 0.79 KMT2A (0.44) ALDH1A1KMT2AMEN1RECQLALOX15
SCHEMBL14823291 0.78 LMNA (0.48) ALDH1A1KMT2ASMN1; SMN2KDM4EHPGD
SCHEMBL14424402 0.78 ALOX15 (0.50) ALDH1A1KMT2AMEN1ALOX15ATM
SCHEMBL2461968 0.78 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1MAOAMAOB
SCHEMBL2469364 0.78 CA4 (0.61) ALDH1A1KMT2AMEN1MAOBSMN1; SMN2
SCHEMBL5515233 0.77 LTA4H (0.41) ALDH1A1RECQLALOX15ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410303-B2 Direct conversion of phenols into amides and esters of benzoic acid The Florida State University Research Foundation, Inc. (US) 2013-04-02 US disclosed
US-8410303-B2 Direct conversion of phenols into amides and esters of benzoic acid The Florida State University Research Foundation, Inc. (US) 2013-04-02 US disclosed
US-8410303-B2 Direct conversion of phenols into amides and esters of benzoic acid The Florida State University Research Foundation, Inc. (US) 2013-04-02 US disclosed
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID The Florida State University Research Foundation, Inc. (US) 2011-09-29 US disclosed
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID The Florida State University Research Foundation, Inc. (US) 2011-09-29 US disclosed
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID The Florida State University Research Foundation, Inc. (US) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237798-A1 DIRECT CONVERSION OF PHENOLS INTO AMIDES AND ESTERS OF BENZOIC ACID DDC, NISCH, TST ALDH1A1 1033/4885KMT2A 2465/4885MEN1 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.